Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-02-11T14:02:14.502Z Has data issue: false hasContentIssue false

Anticonvulsants and Megaloblastic Anaemia

Published online by Cambridge University Press:  08 February 2018

John Johnson*
Affiliation:
Netherne Hospital, Coulsdon
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The development of megaloblastic anaemia as a complication of anticonvulsant therapy is now well recognized, and a total of thirty cases has been recorded.

Badenoch (1) reported the first detailed studies of megaloblastic anaemia developing in epileptic patients treated with phenobarbitone and epanutin, whilst Fuld and Moorhouse (6) reported the association with primidone (Mysoline) alone. In all the cases reported, the anaemia responded to folic acid therapy, whilst anticonvulsant drugs were continued.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1959 

References

1. Badenoch, J., Proc. Roy. Soc. Med., 1954, 47, 426.Google Scholar
2. Benians, R. C., and Hunter, R. A., J. Ment. Sci., 1957, 103, 606.Google Scholar
3. Chanarin, I., Elmes, B. M., and Mollin, D. L., Brit. Med. J., 1958, ii, 80.CrossRefGoogle Scholar
4. Dawson, D. W., and Johnson, J., ibid., 1958, i, 397.Google Scholar
5. Denborough, M. A., Retief, F. P., and Witts, L. J., ibid., 1958, i, 1213.Google Scholar
6. Fuld, H., and Moorhouse, E. H., ibid., 1956, i, 1021.Google Scholar
7. Girdwood, R. H., and Lenman, J. A. R., ibid., 1956, i, 146 Google Scholar
8. Kidd, P., and Mollin, D. L., ibid., 1957, ii, 974.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.